Related Experiment Videos
Three leflunomide metabolite analogs.
S Ghosh1, J D Jennissen, Y Zheng
1Department of Structural Biology (Drug Discovery Program), Parker Hughes Institute, 2665 Long Lake Road, Suite 330, St Paul, MN 55113, USA. sghosh@ih.org.
Acta Crystallographica. Section C, Crystal Structure Communications
|October 12, 2000
Summary
Three novel compounds, PHI492, PHI493, and PHI495, are identified as potent inhibitors of Bruton's tyrosine kinase (BTK). Their similar molecular structures exhibit unique crystal packing and hydrogen-bonding interactions influencing their inhibitory potential.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Biochemistry
Background:
- Bruton's tyrosine kinase (BTK) is a critical regulator in B-cell signaling pathways.
- Dysregulation of BTK is implicated in various B-cell malignancies and autoimmune diseases.
- Development of selective BTK inhibitors is a key therapeutic strategy.
Purpose of the Study:
- To synthesize and characterize novel compounds as potential BTK inhibitors.
- To investigate the structure-activity relationships of these compounds.
- To elucidate the molecular interactions governing their inhibitory activity.
Main Methods:
- Chemical synthesis of title compounds: PHI492, PHI493, and PHI495.
- X-ray crystallography to determine molecular structures and crystal packing.
- Analysis of hydrogen-bonding networks and intermolecular interactions.
Main Results:
- The title compounds are potent inhibitors of Bruton's tyrosine kinase (BTK).
- Structural analysis revealed similar hydrogen-bonding networks and crystal packing across the compounds.
- Intermolecular cyano-amide hydrogen bonding dictates alternating molecular orientation in the crystal lattice.
- PHI492, a positional isomer of PHI493, exhibits distinct crystallization behavior due to the absence of intermolecular O-H.O hydrogen bonds.
Conclusions:
- The studied compounds represent a promising class of BTK inhibitors.
- Molecular structure, hydrogen bonding, and crystal packing significantly influence BTK inhibition.
- Understanding these interactions can guide the design of more effective BTK-targeted therapies.